Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1, Open-label, Drug-drug Interaction Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects

NCT02080780 is registered in ClinicalTrials.gov with Ventrus Biosciences, Inc as lead sponsor.

NCT NCT02080780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02080780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1, Open-label, Drug-drug Interaction Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects
Lead sponsor
Ventrus Biosciences, Inc
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2013
Completion date
October 31, 2013
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clarithromycin/diltiazem [va drug interaction]